| Previous Close | 146.72 |
| Open | 147.97 |
| Bid | 145.00 x 100 |
| Ask | 153.00 x 400 |
| Day's Range | 144.59 - 150.17 |
| 52 Week Range | 36.71 - 192.94 |
| Volume | 1,044,630 |
| Avg. Volume | 1,162,539 |
| Market Cap | 7.9B |
| Beta | 2.36 |
| PE Ratio (TTM) | -17.21 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool•17 hours ago
How Things Look for Opko Health, Inc. in 3 Charts
It hasn't been a great year so far for Opko Health, but the future could be brighter.
- Investor's Business Daily•7 days ago
Could Tesaro Overcome Clovis' Lead On Combos With Merck & Co.?
Tesaro's Zejula would likely outperform drugs from Clovis and AstraZeneca in immuno-oncology combinations with Merck, Bristol or Roche.
- Barrons.com•7 days ago
Biotech ETFs: Still Riding High
The biotechnology-stock rally continues. The SPDR S&P Biotech (XBI) and the iShares Nasdaq Biotechnology (IBB), among the highest-flying exchange-traded funds yesterday, both hit their 52-week highs on ...
